DSM Composite Resins (Switzerland) and Sinopec Jinling Petrochemical Corporation (PRC, The People’s Republic of China) have reached an agreement whereby DSM acquires another 25% of the shares in the Jinling-DSM Resins Ltd. (JDR) joint venture.
DSM Venturing is to invest USD 1.5 million in CreAgri Inc., a nutraceutical company focusing on the discovery and development of antioxidant polyphenols extracted from olive pulp.
On 1 October, Peter Elverding, the chairman of DSM’s Managing Board of Directors, presented the DSM People Award 2002 to the management team of the ABS plant in Geleen, the Netherlands. The team won the award for their work in finding alternative employment for the 240 employees affected by the closure of the plant.
The Dream Action that DSM launched this year inspired more than 1,100 DSM employees in 30 countries to put forward a total of over 700 ideas. A select number of these were nominated for the Dream Action Awards. The awards were announced by the judging committee on Wednesday October 2 at the DSM Head Office in Heerlen, the Netherlands, in the presence of Her Majesty Queen Beatrix of the Netherlands and all the nominees from all over the world.
DSM is going to expand its production capacity for Dyneema, the superstrong polyethylene fiber, by at least 40% by building two new production lines in Greenville (North Carolina, USA) with a combined capacity of 1,300/1,600 tons per year (depending on product grade mix).
Agennix Inc. and DSM Pharmaceutical Products, a business group of DSM N.V., today jointly announced the opening of a new manufacturing facility on DSM’s fermentation site in Capua, Italy.
The Swiss based healthcare group Roche and the Dutch life science products and performance materials company DSM announced today that DSM intends to acquire Roche’s Vitamins and Fine Chemicals Division. On the basis of the discussions to date, the two companies have reached basic agreement on price and payment terms and expect subsequently to conclude on an exclusive basis a contract on all terms of the transaction.
DSM (the Netherlands) and Sinopec (People’s Republic of China) have signed a founding agreement to start the joint venture DSM Nanjing Chemical Company
(DNCC). DSM Fibre Intermediates will participate 60% in this joint venture whereas Sinopec Nanjing Chemical Industries Co. Ltd. will represent the other 40% of the shares.
Koos Mencke, René Steeman and Jean Beugels of DSM N.V. in Heerlen, the Netherlands, will be recognized Sunday, 18 August, by the world’s largest scientific society for developing better processes and new applications for a super-strong fiber used in lightweight personal and vehicle armor. The DSM team will be honored as Heroes of Chemistry at the American Chemical Society’s 224th national meeting in Boston, along with chemists and chemical engineers from DuPont and Solutia Inc.
The first armored cockpit door to have been officially certified by the American FAA (Federal Aviation Administration) contains the super strong fiber Dyneema produced by DSM. Dyneema from DSM has been used in various protective applications for many years, but the fiber’s use in the civil aircraft industry is new.
Last year, DSM filed more patent applications in the European Union than any other company, according to the records of the European Patent Office (EPO).
DSM’s profit on ordinary activities after taxation for the second quarter of 2002 (including DSM Petrochemicals) amounted to EUR 120 million, up 13% from the second quarter of 2001 and 76% from the first quarter of 2002.
Two DSM employees have won the New Venture 2002 award in a business plan contest for start-ups organized by De Baak, the management centre of the Confederation of Netherlands Industry and Employers (VNO-NCW). Their entry was a business plan for Purisoil, an innovative soil remediation technology. The award consists of a cash prize of EUR 25,000. The DSM Venturing & Business Development business group is currently working on the commercialization of this DSM invention. DSM expects to spin out the business concerned (Terreco) in the future.
DSM has decided to invest EUR 7 million in the basic engineering for a new biopharmaceutical plant in Canada. The new multi-product facility will comprise four fermentors with a combined capacity of more than 60,000 litres and will also include downstream processing and all necessary infrastructure. It will be ...
The sale of DSM’s petrochemicals business to Saudi Basic Industries Corporation (SABIC) has been completed. As a result, the activities of DSM Petrochemicals in Geleen (Netherlands) and Gelsenkirchen (Germany) have been transferred to SABIC with retroactive effect from 1 January 2002.
The European Commission has approved the takeover of DSM’s petrochemical activities by an affiliate of Saudi Arabian Basic Industries Corporation (SABIC). The transfer of the businesses involved is expected ...
The festivities organized to celebrate DSM's centennial began today with a worldwide breakfast at over 150 sites in more than 35 countries. During this breakfast all of DSM's 22,000 employees were informed about the company's 'Dream Action'.
The First Prize of the competition for the DSM Award for Chemistry and Technology 2002 has been granted to Richard van Delden (27) of Veendam and Mrs Dominique de Seny (27) of Liège.
Q1 2002 operating profit clearly better than in Q4 2001. The net profit on ordinary activities was EUR 68 million, which is EUR 38 million (36%) lower than in the first quarter of 2001 but EUR 12 million (21%) higher than in the fourth quarter of 2001.
DSM is to split up its DSM Fine Chemicals business group as of 1 July 2002 into two new business groups: DSM Pharmaceutical Products and DSM Fine Chemicals.
DSM and SABIC, the largest petrochemicals producer in the Middle East, have reached an agreement in principle on the purchase of DSM's petrochemicals business by SABIC.
Professor C.A.J. Herkströter (1937) is to be the new chairman of the Supervisory Board of Directors of DSM N.V. He will succeed Mr H.H.F. Wijffels, whose term of office ends this year.
DSM Special Products recently started producing Purox B and Purox S at its new facilities in Rotterdam (Netherlands). These new DSM grades of benzoic acid and sodium benzoate, respectively, represent a breakthrough in terms of product quality and purity.
DSM announces today the appointment of Mr Wesley P. Wheeler as President & CEO, DSM Pharmaceuticals Inc. (former DSM Catalytica Pharmaceuticals), as well as Business Unit Director Dose Manufacturing and Supply.
Car manufacturers VW and Audi are to use the polymer Stanyl®, manufactured by DSM, in the fuel-injection system of their new generation of diesel engines.
DSM's net profit for the fourth quarter of 2001 was EUR 1,031 million, compared with EUR 119 million in the fourth quarter of 2000. This increase is mainly attributable to the sale of the depositary receipts of Energie Beheer Nederland.
DSM and Avantium Technologies announced that they have entered into a cooperation agreement to discover new and improved catalytic systems relevant to DSM's life sciences business.
DSM has invested USD 3 million in the NextGen Enabling Technologies Fund. This is a Venture Capital Fund (VCF) located in Santa Barbara (California, USA) which is focusing on investments in early stage companies in the area of High Performance Materials for use in for example electronics, optics, communication hardware and biomedical applications.
As of 1 January 2002, John McLaren (38) is the Vice President of Corporate Communications at DSM. McLaren is responsible for the total communications policy of DSM.
Novozymes and DSM announce the signing of an agreement under which DSM grants a worldwide, semi-exclusive license and other rights to Novozymes for Novozymes' phytase products.
